Triggering through CD40 promotes interleukin-4-induced CD23 production and enhanced soluble CD23 release in atopic disease.
The pathogenesis of atopic disease is closely linked to the overproduction of IgE. CD23 and CD40 are two cellular receptors involved in the regulation of IgE production and both receptors are elevated in atopic disease. We have examined the role of CD40 in the regulation of CD23 and soluble CD23 production in healthy and atopic donors. Triggering of the B cell CD40 receptor directly enhances interleukin (IL)-4-mediated up-regulation of CD23 at both the protein and the mRNA level. When atopic donors were studied, the synergistic effect of CD40 triggering on the IL-4-induced up-regulation of CD23 and soluble CD23 (sCD23) was enhanced and there was a relative skewing toward production of sCD23. These studies implicate the CD40 receptor in the hyperproduction of CD23 and sCD23 in atopic disease and suggest that abnormalities may exist in the cellular pathways leading to sCD23 production.
Paterson
R L
RL
Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206, USA.
Lack
G
G
Domenico
J M
JM
Delespesse
G
G
Leung
D Y
DY
Finkel
T H
TH
Gelfand
E W
EW
D000911:Antibodies, Monoclonal / Q000276:immunology; D015703:Antigens, CD / Q000032:analysis; D001402:B-Lymphocytes / Q000276:immunology; D019013:CD40 Antigens / Q000502:physiology*; D002478:Cells, Cultured; D002648:Child; D002675:Child, Preschool; D006801:Humans; D006967:Hypersensitivity / Q000378:metabolism*; D015847:Interleukin-4 / Q000494:pharmacology*; D017455:Receptors, IgE / Q000096:biosynthesis*; D018123:Receptors, Interleukin / Q000032:analysis; D019948:Receptors, Interleukin-4
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D019013:CD40 Antigens; D017455:Receptors, IgE; D018123:Receptors, Interleukin; D019948:Receptors, Interleukin-4; D015847:Interleukin-4